Hormone Refractory Prostate Cancer

Understanding    Treating    Maintaining Quality of Life

Home
What's New
News
What To Do First
On Line Support List
Proven Treatments
Potential Treatments
Managing Symptoms
Diagnostic Tests
Information Resources
FAQ
Support HRPCA.org

 

NEWS 

This page provides some of the latest news related to hormone refractory prostate cancer.  The newest items appear at the top of the list.

As of 5/22/2009, Johnson and Johnson is planning on purchasing Courgar
Biotechnology -- a deal that hopefully will not slow down the development of Abiraterone Acetate.














 
 

This information is provided for educational purposes only and does not replace or amend professional medical advice. Unless otherwise stated and credited, the content of this website is by and the opinion of and copyright © 2001-2010 by Howard Hansen. All Rights Reserved.  Our policy regarding privacy,  right to reprint and contact information are at About Us. We are a 501(c)(3) not-for-profit public charity.